- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07816445
Pilot Study of an Interparental Conflict Intervention for Separating or Divorcing Parents
Pilot Study to Test Effects of a New Interparental Conflict Intervention for Separating or Divorcing Parents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized pilot trial of a new, scalable intervention for separating or divorcing parents experiencing interparental conflict. The intervention was developed by adapting components of existing evidence-based interventions using human-centered design methods. The intervention is designed to teach parents skills for reducing children's exposure to interparental conflict and protecting children's mental health and well-being.
Approximately 94 parents who are court ordered to participate in an intervention addressing interparental conflict will be randomly assigned to either the new intervention or an existing court-based program. The new intervention is expected to include an orientation session followed by three or four digital sessions. The pilot study will evaluate implementation outcomes, including feasibility, acceptability, appropriateness, and usability, as well as preliminary effects on interparental conflict and children's internalizing and externalizing problems. The study will also examine parents' use of skills intended to protect children from interparental conflict and interpersonal violence and parents' emotion-regulation skills.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sharlene A Wolchik, PhD
- Email: wolchik@asu.edu
Study Contact Backup
- Name: Karey L O'Hara, PhD
- Phone Number: 480-727-6136
- Email: klohara@asu.edu
Study Locations
-
-
Arizona
-
Tempe, Arizona, United States, 85287
- Recruiting
- Arizona State University
-
Contact:
- Karey L O'Hara, PhD
- Phone Number: 480-727-3623
- Email: klohara@asu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- Fluent in English
- Court ordered to attend an intervention to reduce interparental conflict
Exclusion Criteria: None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Family COMPASS
Participants receive Family COMPASS, a four-session parenting intervention for parents experiencing high levels of interparental conflict following separation or divorce.
|
Family COMPASS (Conflict Management through Purposeful Awareness, Strategies, and Support) is a manualized, trauma-informed parenting intervention designed to reduce children's exposure to interparental conflict following parental separation or divorce.
The intervention consists of four highly structured, approximately 30-minute sessions delivered virtually or in person by trained personnel.
It focuses on strengthening parents' emotion regulation, communication, co-parenting, conflict management, and safety planning skills.
|
|
Active Comparator: Families in Transition (FIT)
Participants receive FIT, an existing 90-minute online parent education program designed to help separating or divorcing parents reduce interparental conflict and children's exposure to conflict.
|
FIT is a 90-minute online parent education program developed by the Superior Court of Maricopa County in collaboration with the National Center for State Courts.
The program includes four modules, a film, and interactive activities.
It validates parents' difficult feelings toward their co-parent while emphasizing behavior change to protect children from interparental conflict.
Content addresses the effects of interparental conflict on children, prioritizing children's needs, developing a child-focused vision for the future, and using practical strategies to reduce conflict behaviors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Anxiety Symptoms
Time Frame: Baseline and 30 days after program completion
|
Parent-reported child anxiety symptoms assessed using the Anxiety subscale of the Revised Child Anxiety and Depression Scale-25 Parent Version (RCADS-25-P).
The Anxiety subscale contains 15 items rated from 0 (Never) to 3 (Always).
Raw scores range from 0 to 45, with higher scores indicating greater anxiety symptoms.
|
Baseline and 30 days after program completion
|
|
Child Depressive Symptoms
Time Frame: Baseline and 30 days after program completion
|
Parent-reported child depressive symptoms assessed using the Depression subscale of the Revised Child Anxiety and Depression Scale-25 Parent Version (RCADS-25-P).
The Depression subscale contains 10 items rated from 0 (Never) to 3 (Always).
Raw scores range from 0 to 30, with higher scores indicating greater depressive symptoms.
|
Baseline and 30 days after program completion
|
|
Child Irritability/Anger
Time Frame: Baseline and 30 days after program completion
|
Parent-reported child irritability and anger assessed using the irritability/anger item of the DSM-5 Level 1 Cross-Cutting Symptom Measure-Parent/Guardian-Rated Measure for Children Ages 6-17.
The item is rated from 0 (Not at all) to 4 (Nearly every day).
Scores range from 0 to 4, with higher scores indicating greater irritability/anger.
|
Baseline and 30 days after program completion
|
|
Child Attention Problems
Time Frame: Baseline and 30 days after program completion
|
Parent-reported child attention problems assessed using the attention item of the DSM-5 Level 1 Cross-Cutting Symptom Measure-Parent/Guardian-Rated Measure for Children Ages 6-17.
The item is rated from 0 (Not at all) to 4 (Nearly every day).
Scores range from 0 to 4, with higher scores indicating greater attention problems.
|
Baseline and 30 days after program completion
|
|
Interparental Conflict
Time Frame: Baseline and 30 days after program completion
|
Parent-reported interparental conflict assessed using the 13-item intensity and frequency subscales of the Children's Perception of Interparental Conflict Scale, adapted for parent report.
Items are rated on a 3-point scale and appropriately reverse-scored.
Using summed item scores coded from 0 to 2, total scores range from 0 to 26, with higher scores indicating greater interparental conflict.
|
Baseline and 30 days after program completion
|
|
Intervention Feasibility
Time Frame: Approximately 30 days after program completion
|
Parent-reported feasibility assessed using the 4-item Feasibility of Intervention Measure (FIM).
Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20.
Higher scores indicate greater perceived feasibility.
|
Approximately 30 days after program completion
|
|
Intervention Acceptability
Time Frame: Approximately 30 days after program completion
|
Parent-reported acceptability assessed using the 4-item Acceptability of Intervention Measure (AIM).
Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20.
Higher scores indicate greater acceptability.
|
Approximately 30 days after program completion
|
|
Intervention Appropriateness
Time Frame: Approximately 30 days after program completion
|
Parent-reported appropriateness assessed using the 4-item Intervention Appropriateness Measure (IAM).
Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20.
Higher scores indicate greater perceived appropriateness.
|
Approximately 30 days after program completion
|
|
Intervention Usability
Time Frame: Approximately 30 days after program completion
|
Parent-reported intervention usability assessed using the 10-item Intervention Usability Scale (IUS).
Items are rated on a 5-point agreement scale.
Positively and negatively worded items are scored according to standard IUS scoring procedures, and the summed score is multiplied by 2.5.
Total scores range from 0 to 100, with higher scores indicating greater perceived intervention usability.
|
Approximately 30 days after program completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Regulation Difficulties
Time Frame: Baseline and 30 days after program completion
|
Parent-reported difficulties in emotion regulation assessed using the 16-item Difficulties in Emotion Regulation Scale-Short Form (DERS-SF).
Items are rated from 1 (Almost Never) to 5 (Almost Always), with total scores ranging from 16 to 80. Higher scores indicate greater difficulties with emotion regulation.
|
Baseline and 30 days after program completion
|
|
Confidence in Making a Safety Plan for Self
Time Frame: Baseline and 30 days after program completion
|
Parent-reported confidence in the ability to make a safety plan for oneself, assessed using a single-item rating scale ranging from 0 (Not at all confident) to 100 (Completely confident).
Higher scores indicate greater confidence in safety planning.
|
Baseline and 30 days after program completion
|
|
Confidence in Making a Safety Plan for Children
Time Frame: Baseline and 30 days after program completion
|
Parent-reported confidence in the ability to make a safety plan for one's child or children, assessed using a single-item rating scale ranging from 0 (Not at all confident) to 100 (Completely confident).
Higher scores indicate greater confidence in safety planning.
|
Baseline and 30 days after program completion
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00015304
- R34MH126052 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.